The PE Ratio as of September 2024 (TTM) for Vor Biopharma Inc. (VOR) is -0.52

According to Vor Biopharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.52. This represents a change of -52.24% compared to the average of -1.09 of the last 4 quarters.

Vor Biopharma Inc. (VOR) Historical PE Ratio (quarterly & annually)

How has VOR PE Ratio performed in the past?

The mean historical PE Ratio of Vor Biopharma Inc. over the last ten years is -35.89. The current -0.52 PE Ratio has changed 44.90% with respect to the historical average. Over the past ten years (40 quarters), VOR's PE Ratio was at its highest in in the September 2019 quarter at -0.26. The PE Ratio was at its lowest in in the December 2019 quarter at -29.40.

Vor Biopharma Inc. (VOR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vor Biopharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vor Biopharma Inc. (VOR) Average PE Ratio

How has VOR PE Ratio performed in the past?

The current PE Ratio of Vor Biopharma Inc. (VOR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vor Biopharma Inc. (VOR) PE Ratio vs. Peers

How is VOR’s PE Ratio compared to its peers?

Vor Biopharma Inc.’s PE Ratio is greater than Gracell Biotechnologies Inc. (-12.26), greater than Theseus Pharmaceuticals, Inc. (-3.19), greater than Monte Rosa Therapeutics, Inc. (-3.11), greater than Design Therapeutics, Inc. (-5.23), greater than Erasca, Inc. (-3.94), greater than Edgewise Therapeutics, Inc. (-14.14), less than Talaris Therapeutics, Inc. (-0.20), greater than Adicet Bio, Inc. (-0.98), greater than Cullinan Oncology, Inc. (-6.96), greater than Nuvalent, Inc. (-32.10), greater than Ventyx Biosciences, Inc. (-0.89), greater than Arcellx, Inc. (-70.75), greater than Kiniksa Pharmaceuticals, Ltd. (-173.03), less than Bolt Biotherapeutics, Inc. (-0.37), greater than Day One Biopharmaceuticals, Inc. (-7.39), less than Lyra Therapeutics, Inc. (-0.18), greater than Autolus Therapeutics plc (-4.55), greater than Foghorn Therapeutics Inc. (-4.49), greater than Shattuck Labs, Inc. (-2.08), greater than Kymera Therapeutics, Inc. (-21.01), greater than Nurix Therapeutics, Inc. (-8.82),

Build a custom stock screener for Vor Biopharma Inc. (VOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vor Biopharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vor Biopharma Inc. (VOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vor Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.